Shilpa Medicare Q1 Results
- BSE: 530549
- NSE: SHILPAMED
- ISIN: INE790G01031
- Sector: Biotechnology & Drugs
BSE
965.55
-8.05 (-0.83%)
-8.05 (-0.83%)Volume32.74 K
Updated: Wed 14 Oct, 2026 | 15:29:45
NSE
962.10-11.50 (-1.18%)
-11.50 (-1.18%)Volume5.34 L
Updated: Wed 14 Oct, 2026 | 15:50:04
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹465.78 Cr.(44.90%)
- Operating Profit₹101.06 Cr.(61.14%)
- Profit After Tax₹100.89 Cr.(115.18%)
- Operating Margin21.70%(11.21%)
Note: Comparison is on YoY basis
Quarterly - Shilpa Medicare Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 364.72 | 322.81 | 12.98% | 246.02 | 40.96% |
| Depreciation/ Amortization | 35.20 | 30.61 | 14.99% | 27.11 | 21.71% |
| Operating Income | 101.06 | 114.90 | -12.05% | 46.49 | 61.14% |
| Net Income | 100.89 | 107.80 | -6.41% | 14.06 | 115.18% |
| Other Operating Expenses Total | 94.66 | 88.68 | 6.74% | 53.96 | 38.39% |
| Net Income Before Taxes | 98.06 | 120.46 | -18.59% | 28.68 | 97.78% |
| Total Revenue | 465.78 | 437.72 | 6.41% | 292.51 | 44.90% |
| Selling/ General/ Admin Expenses Total | 99.71 | 86.56 | 15.19% | 72.14 | 21.87% |
| Diluted Normalized EPS | 5.16 | 2.15 | 140.03% | 0.73 | 115.45% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.